CDT Equity, Inc. (CDT)
0.91
-0.08
(-8.08%)
USD |
NASDAQ |
Oct 05, 16:00
0.99
+0.08
(+8.79%)
After-Hours: 20:00
CDT Equity EPS Diluted (Quarterly) : -217.68 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -217.68 |
| March 31, 2026 | -1390.56 |
| December 31, 2025 | -57860.31 |
| September 30, 2025 | -82256.50 |
| June 30, 2025 | -273134.0 |
| March 31, 2025 | -917385.0 |
| December 31, 2024 | -1.303M |
| September 30, 2024 | -5.560M |
| June 30, 2024 | -5.467M |
| March 31, 2024 | -3.628M |
| Date | Value |
|---|---|
| December 31, 2023 | -1.145M |
| September 30, 2023 | 494250.0 |
| June 30, 2023 | -2.012M |
| March 31, 2023 | -2.086M |
| December 31, 2022 | -3.164M |
| September 30, 2022 | -984750.0 |
| June 30, 2022 | -510000.0 |
| March 31, 2022 | -1.100M |
| December 31, 2021 | -18750.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Windtree Therapeutics, Inc. | -1.085 |
| Lifecore Biomedical, Inc. | -0.1897 |
| Codexis, Inc. | -0.1318 |
| Navidea Biopharmaceuticals, Inc. | -- |
| Biostax Corp. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.641M |
| Total Expenses (Quarterly) | 4.641M |
| Enterprise Value | 0.4599M |
| Earnings Yield | -15.57M% |
| Normalized Earnings Yield | -15.50M |